These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 17692152)
1. Clinical and economic impact of using macrogol 3350 plus electrolytes in an outpatient setting compared to enemas and suppositories and manual evacuation to treat paediatric faecal impaction based on actual clinical practice in England and Wales. Guest JF; Candy DC; Clegg JP; Edwards D; Helter MT; Dale AK; Fell J; Cosgrove M; Debelle G Curr Med Res Opin; 2007 Sep; 23(9):2213-25. PubMed ID: 17692152 [TBL] [Abstract][Full Text] [Related]
2. Modelling the costs and consequences of treating paediatric faecal impaction in Australia. Guest JF; Clegg JP Curr Med Res Opin; 2006 Jan; 22(1):107-19. PubMed ID: 16393437 [TBL] [Abstract][Full Text] [Related]
3. Disimpaction of children with severe constipation in 3-4 days in a suburban clinic using polyethylene glycol with electrolytes and sodium picosulphate. Jordan-Ely J; Hutson JM; Southwell BR J Paediatr Child Health; 2015 Dec; 51(12):1195-8. PubMed ID: 26059611 [TBL] [Abstract][Full Text] [Related]
4. Rectal fecal impaction treatment in childhood constipation: enemas versus high doses oral PEG. Bekkali NL; van den Berg MM; Dijkgraaf MG; van Wijk MP; Bongers ME; Liem O; Benninga MA Pediatrics; 2009 Dec; 124(6):e1108-15. PubMed ID: 19948614 [TBL] [Abstract][Full Text] [Related]
5. Treatment of faecal impaction with polyethelene glycol plus electrolytes (PGE + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy. Candy DC; Edwards D; Geraint M J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):65-70. PubMed ID: 16819379 [TBL] [Abstract][Full Text] [Related]
6. Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation. Shepherd J; Brodin H; Cave C; Waugh N; Price A; Gabbay J Health Technol Assess; 2004 Oct; 8(39):iii-iv, 1-125. PubMed ID: 15461877 [TBL] [Abstract][Full Text] [Related]
7. A Retrospective Study Comparing Polyethylene Glycol-Electrolyte Solution With Magnesium Citrate for Treatment of Fecal Disimpaction. Philichi L; Yuwono M Gastroenterol Nurs; 2018; 41(2):141-144. PubMed ID: 29596128 [TBL] [Abstract][Full Text] [Related]
8. A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1. Connock M; Juarez-Garcia A; Frew E; Mans A; Dretzke J; Fry-Smith A; Moore D Health Technol Assess; 2006 Jun; 10(20):iii-iv, ix-113. PubMed ID: 16729919 [TBL] [Abstract][Full Text] [Related]
9. Golytely: a new approach to faecal impaction in old age. Puxty JA; Fox RA Age Ageing; 1986 May; 15(3):182-4. PubMed ID: 3739857 [TBL] [Abstract][Full Text] [Related]
11. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation. Shepherd J; Jones J; Takeda A; Davidson P; Price A Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047 [TBL] [Abstract][Full Text] [Related]
12. Health economic impact of olopatadine compared to branded and generic sodium cromoglycate in the treatment of seasonal allergic conjunctivitis in the UK. Guest JF; Clegg JP; Smith AF Curr Med Res Opin; 2006 Sep; 22(9):1777-85. PubMed ID: 16968581 [TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of testing for hepatitis C in former injecting drug users. Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891 [TBL] [Abstract][Full Text] [Related]
14. Use of gastrografin in the management of faecal impaction in patients with severe chronic constipation: a randomized clinical trial. Gu L; Ding C; Tian H; Yang B; Zhang X; Hua Y; Gong J; Li N ANZ J Surg; 2019 Mar; 89(3):239-243. PubMed ID: 30294848 [TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of a general practitioner with special interests led dermatology service in primary care. Coast J; Noble S; Noble A; Horrocks S; Asim O; Peters TJ; Salisbury C BMJ; 2005 Dec; 331(7530):1444-9. PubMed ID: 16339217 [TBL] [Abstract][Full Text] [Related]
16. Movicol in treatment of constipation and faecal impaction. Ungar A Hosp Med; 2000 Jan; 61(1):37-40. PubMed ID: 10735152 [TBL] [Abstract][Full Text] [Related]
17. Macrogol 3350 plus electrolytes for chronic constipation in children: a single-centre, open-label study. Hardikar W; Cranswick N; Heine RG J Paediatr Child Health; 2007; 43(7-8):527-31. PubMed ID: 17635680 [TBL] [Abstract][Full Text] [Related]
18. Economic impact of low dose polyethylene glycol 3350 plus electrolytes compared with lactulose in the management of idiopathic constipation in the UK. Christie AH; Culbert P; Guest JF Pharmacoeconomics; 2002; 20(1):49-60. PubMed ID: 11817992 [TBL] [Abstract][Full Text] [Related]
19. Use of polyethylene glycol in functional constipation and fecal impaction. Mínguez M; López Higueras A; Júdez J Rev Esp Enferm Dig; 2016 Dec; 108(12):790-806. PubMed ID: 27871178 [TBL] [Abstract][Full Text] [Related]
20. An economic analysis of specialist heart failure nurse management in the UK; can we afford not to implement it? Stewart S; Blue L; Walker A; Morrison C; McMurray JJ Eur Heart J; 2002 Sep; 23(17):1369-78. PubMed ID: 12191748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]